Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 10:1:130.
doi: 10.1186/1752-1947-1-130.

Rhabdomyolysis due to the additive effect of statin therapy and hypothyroidism: a case report

Ekrem Yeter  1 , Telat Keles, Tahir Durmaz, Engin Bozkurt
Affiliations

Rhabdomyolysis due to the additive effect of statin therapy and hypothyroidism: a case report

Ekrem Yeter et al. J Med Case Rep. .

Abstract

We describe a patient with previously undiagnosed hypothyroidism who developed rhabdomyolysis while taking a statin. He had no other precipitating factors. The statin was stopped, intravenous fluids were started immediately and L-thyroxin was given after confirming the diagnosis of hypothyroidism. His symptoms improved over a few days. Because rhabdomyolysis is a rare but potentially life threatening disorder when complicated by acute tubular necrosis and renal failure, physicians must pay special attention when starting statins in patients with hyperlipidemia.

PubMed Disclaimer

References

    1. Tokinaga K, Oeda T, Suziki Y, Matsushima Y. HMG CoA Reductase Inhibitors might ause high elevations of creatine phosphokinase in patients with unnoticed hypothyroidism. Endocrine Journal. 2006;53:401–405. doi: 10.1507/endocrj.K04-144. - DOI - PubMed
    1. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003;289:1681–1690. doi: 10.1001/jama.289.13.1681. - DOI - PubMed
    1. Larosa JC, He J, Vupputuri S. Effect of statins on risk coronary disease. JAMA. 1999;282:2340–2346. doi: 10.1001/jama.282.24.2340. - DOI - PubMed
    1. Omar MA, Willson JP, Cox TS. Rhabdomyolysis and HMG-COA reductase inhibitors. Ann Pharmacother. 2001;35:1096–1107. doi: 10.1345/aph.10228. - DOI - PubMed
    1. Barahona MJ, Mauri A, Sucuzza N, Paredes R, Wanger AM. Hypothroidism as a cause of Rhabdomyolysis. Endocr J. 2002;49:621–623. doi: 10.1507/endocrj.49.621. - DOI - PubMed

LinkOut - more resources